Therapeutic effect and pharmacological analysis of Betaloc on dilated cardiomyopathy
Objective To investigate the clinical efficacy and pharmacological effects of Betaloc in patients with dilated cardiomyopathy. Methods 80 cases of patients with dilated cardiomyopathy treated by Hangzhou First People's Hospital from January 2013 to January 2017 were selected and randomly divided control group and experimental group, 40 cases in each group. The control group was given routine treatment, while the experimental group on the basis of routine treatment were given Betaloc, observe the clinical effect on the treatment of patients. The 6min walking distance (MD), left ventricular ejection fraction (LVEF), heart rate (HR), left ventricular end diastolic diameter (LVED) were compared and the adverse reaction. Results After treatment, the patients in the experimental group of MD (210.34±2.63)m, LVEF (36.85±1.25)%, HR (65.37±4.62) times/min, LVED (63.27±4.57)mm, were better than that of the control group (P<0.05). The adverse reaction of the experimental group was significantly less than the control group, (P<0.05). Conclusion Betaloc can significantly improve the clinical parameters of patients with dilated cardiomyopathy, and can avoid adverse reactions, and is conducive to the health of patients.
NETL
NSTL
万方数据
维普
